Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification Read more about Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies Read more about A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies
Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues Read more about Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues
Immunohistochemical detection of PD-L1 among diverse human neoplasms in a reference laboratory: observations based upon 62,896 cases Read more about Immunohistochemical detection of PD-L1 among diverse human neoplasms in a reference laboratory: observations based upon 62,896 cases
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL Read more about Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL
American Registry of Pathology Expert Opinions Read more about American Registry of Pathology Expert Opinions
Predictive Markers Require Thorough Analytic Validation Read more about Predictive Markers Require Thorough Analytic Validation
Clinicopathologic characteristics and novel biomarkers of aggressive B-cell lymphomas in the nasopharynx Read more about Clinicopathologic characteristics and novel biomarkers of aggressive B-cell lymphomas in the nasopharynx
EBV–Associated Lymphoproliferative Disorders: Update in Classification Read more about EBV–Associated Lymphoproliferative Disorders: Update in Classification
The ever-changing world of gene fusions in cancer: a secondary gene fusion and progression Read more about The ever-changing world of gene fusions in cancer: a secondary gene fusion and progression